E-Newsletter - April 2018

NEW member joins Alliance patient advocate committee

The Alliance Patient Advocate Committee recently welcomed a new member - Paul Leech, of Boston, MA, who will serve as a Patient Advocate on the Alliance Leukemia Committee. Mr. Leech is a leukemia survivor who participated in a clinical trial after
diagnosis. He has subsequently worked closely with many cancer patients as they undergo treatment. He brings more than 25 years of experience in organizational leadership for companies in the UK and North America, has served on Boards throughout the world and is an accomplished public speaker, having most recently led three non-profit organizations.

 

 

 

For other articles in this issue of the Alliance E-News newsletter, see below.

• Spotlight on Trials
  Recent Alliance Protocol Activations
  Alliance Myeloma Committee
  New DCIS Special Study
  Work from Inaugural CCP Junior Faculty Award Recipients
• Alliance in the News
• Group Meeting Highlights
• Guest Columnists
  Eileen O'Reilly, MD and Jeffrey Meyerhardt, MD - Next Generation Approaches
• Revisiting the Alliance Conflict of Interest Policy
• Will Conversion to CTCAE v5 Impact Alliance Trial?
• New Member Join Alliance Patient Advocate Committee
• RFP: Aflac Archie Bleyer Young Investigator Award
• In Memoriam: James F. Holland, MD and Karen Durham